Inflammatory networks in ageing, age-related diseases and longevity

[1]  C. Caruso,et al.  Connexin37 1019 gene polymorphism in myocardial infarction patients and centenarians. , 2007, Atherosclerosis.

[2]  C. Franceschi,et al.  Alpha1-antitrypsin heterozygosity plays a positive role in attainment of longevity , 2007, Biogerontology.

[3]  C. Franceschi,et al.  Immunogenetics, Gender, and Longevity , 2006, Annals of the New York Academy of Sciences.

[4]  K. Vandenbroeck.  Cytokine Gene Polymorphisms in Multifactorial Conditions , 2006 .

[5]  F. Cipollone,et al.  COX-2 and Atherosclerosis , 2006, Journal of cardiovascular pharmacology.

[6]  C. Caruso,et al.  Inflammation, Longevity, and Cardiovascular Diseases , 2006, Annals of the New York Academy of Sciences.

[7]  W. Kalow,et al.  Pharmacogenetics and pharmacogenomics: origin, status, and the hope for personalized medicine , 2006, The Pharmacogenomics Journal.

[8]  Claudio Franceschi,et al.  The Genetics of Human Longevity , 2006, Annals of the New York Academy of Sciences.

[9]  C. Franceschi,et al.  Opposite Role of Pro‐Inflammatory Alleles in Acute Myocardial Infarction and Longevity , 2006, Annals of the New York Academy of Sciences.

[10]  C. Caruso,et al.  Biology of longevity: role of the innate immune system. , 2006, Rejuvenation research.

[11]  C. Franceschi,et al.  Role of the pyrin M694V (A2080G) allele in acute myocardial infarction and longevity: a study in the Sicilian population , 2006, Journal of leukocyte biology.

[12]  G. Cooke.  Pharmacogenetics of multigenic disease: heart disease as an example. , 2006, Vascular pharmacology.

[13]  C. Finch,et al.  Infection, inflammation, height, and longevity. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[14]  C. Funk,et al.  The 5-lipoxygenase pathway in arterial wall biology and atherosclerosis. , 2005, Biochimica et biophysica acta.

[15]  Marco Caruso,et al.  Association between C1019T polymorphism of connexin37 and acute myocardial infarction: a study in patients from Sicily. , 2005, International journal of cardiology.

[16]  L. Jacobs,et al.  Functional consequences of the Asp299Gly Toll-like receptor-4 polymorphism. , 2005, Cytokine.

[17]  G. Pawelec,et al.  Human immunosenescence: is it infectious? , 2005, Immunological reviews.

[18]  Claudio Franceschi,et al.  Innate immunity and inflammation in ageing: a key for understanding age-related diseases , 2005, Immunity & Ageing.

[19]  Jeffrey L. Anderson.  Infection, antibiotics, and atherothrombosis--end of the road or new beginnings? , 2005, The New England journal of medicine.

[20]  C. Franceschi,et al.  Inflamm‐ageing and lifelong antigenic load as major determinants of ageing rate and longevity , 2005, FEBS letters.

[21]  R. Schumann,et al.  Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. , 2005, The Lancet. Infectious diseases.

[22]  C. Finch.  Developmental origins of aging in brain and blood vessels: an overview , 2005, Neurobiology of Aging.

[23]  Ryan T Demmer,et al.  Periodontal Microbiota and Carotid Intima-Media Thickness: The Oral Infections and Vascular Disease Epidemiology Study (INVEST) , 2005, Circulation.

[24]  S. Jelacic,et al.  The TLR4 +896 polymorphism is not associated with lipopolysaccharide hypo-responsiveness in leukocytes , 2005, Genes and Immunity.

[25]  C. Franceschi,et al.  Genes involved in immune response/inflammation, IGF1/insulin pathway and response to oxidative stress play a major role in the genetics of human longevity: the lesson of centenarians , 2005, Mechanisms of Ageing and Development.

[26]  C. Franceschi,et al.  Inflammation and Life-Span , 2005, Science.

[27]  Gerene M Denning,et al.  Potential role of endotoxin as a proinflammatory mediator of atherosclerosis. , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[28]  C. Franceschi,et al.  Role of Toll-like receptor 4 in acute myocardial infarction and longevity. , 2004, JAMA.

[29]  C. Caruso,et al.  Immunity & Ageing: a new journal looking at ageing from an immunological point of view , 2004, Immunity & Ageing.

[30]  G. Fonarow,et al.  Genetic Basis of Atherosclerosis: Part II: Clinical Implications , 2004, Circulation.

[31]  G. O’Keefe,et al.  Genetic determinants of the inflammatory response , 2004, Current opinion in critical care.

[32]  C. Franceschi,et al.  Opposite effects of interleukin 10 common gene polymorphisms in cardiovascular diseases and in successful ageing: genetic background of male centenarians is protective against coronary heart disease , 2004, Journal of Medical Genetics.

[33]  Eileen M. Crimmins,et al.  Inflammatory Exposure and Historical Changes in Human Life-Spans , 2004, Science.

[34]  J. Kaski,et al.  CD14 and toll-like receptor 4: a link between infection and acute coronary events? , 2004, Heart.

[35]  G. Pawelec,et al.  Is immunosenescence infectious? , 2004, Trends in immunology.

[36]  V. Jala,et al.  Leukotrienes and atherosclerosis: new roles for old mediators. , 2004, Trends in immunology.

[37]  A. Lusis,et al.  Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. , 2004, The New England journal of medicine.

[38]  H. Bruunsgaard,et al.  Inflammatory mediators in the elderly , 2004, Experimental Gerontology.

[39]  A. Barabasi,et al.  Network biology: understanding the cell's functional organization , 2004, Nature Reviews Genetics.

[40]  M. Wilcox,et al.  Cardiovascular advantages among the offspring of centenarians. , 2003, The journals of gerontology. Series A, Biological sciences and medical sciences.

[41]  C. Franceschi,et al.  Centenarians as a model for healthy aging. , 2003, Biochemical Society transactions.

[42]  Howard L McLeod,et al.  Pharmacogenomics--drug disposition, drug targets, and side effects. , 2003, The New England journal of medicine.

[43]  S. Humphries,et al.  The molecular genetics of cardiovascular disease: clinical implications , 2003, Journal of internal medicine.

[44]  P. Jansen-Dürr,et al.  A Darwinian-evolutionary concept of age-related diseases , 2003, Experimental Gerontology.

[45]  P. Ridker,et al.  Inflammatory bio‐markers and cardiovascular risk prediction , 2002, Journal of internal medicine.

[46]  S. Humphries,et al.  Common Promoter Variant in Cyclooxygenase-2 Represses Gene Expression: Evidence of Role in Acute-Phase Inflammatory Response , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[47]  D. Schwartz,et al.  Toll-like receptor 4 polymorphisms and atherogenesis. , 2002, The New England journal of medicine.

[48]  G. Pawelec,et al.  Is human immunosenescence clinically relevant? Looking for 'immunological risk phenotypes'. , 2002, Trends in immunology.

[49]  I. Porto,et al.  Inflammatory gene polymorphisms and ischaemic heart disease: review of population association studies , 2002, Heart.

[50]  C. Janeway,et al.  How the immune system protects the host from infection. , 2001, Microbes and infection.

[51]  Peter Libby,et al.  Current Concepts of the Pathogenesis of the Acute Coronary Syndromes , 2001, Circulation.

[52]  R. Albert,et al.  The large-scale organization of metabolic networks , 2000, Nature.

[53]  J. Wilmoth,et al.  Increase of maximum life-span in Sweden, 1861-1999. , 2000, Science.

[54]  C. Franceschi,et al.  Inflamm‐aging: An Evolutionary Perspective on Immunosenescence , 2000 .

[55]  C. Franceschi,et al.  Human immunosenescence: the prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space. , 2000, Vaccine.

[56]  F. Pociot,et al.  Cytokine gene polymorphism in human disease: on-line databases , 1999, Genes and Immunity.

[57]  P. Lipsky,et al.  Cyclooxygenase in biology and disease , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[58]  P. Libby,et al.  Role of macrophage colony-stimulating factor in atherosclerosis: studies of osteopetrotic mice. , 1997, The American journal of pathology.

[59]  Wade Roush,et al.  Live long and prosper? , 1996, Science.

[60]  T. Hirano,et al.  Triggering of the Human Interleukin-6 Gene by Interferon-γ and Tumor Necrosis Factor-α in Monocytic Cells Involves Cooperation between Interferon Regulatory Factor-1, NFκB, and Sp1 Transcription Factors (*) , 1995, The Journal of Biological Chemistry.

[61]  M. Fishbein,et al.  Detection and localization of tumor necrosis factor in human atheroma. , 1990, The American journal of cardiology.

[62]  H. Manev,et al.  5-Lipoxygenase (ALOX5) and FLAP (ALOX5AP) gene polymorphisms as factors in vascular pathology and Alzheimer's disease. , 2006, Medical hypotheses.

[63]  B. Troen,et al.  The biology of aging. , 2003, The Mount Sinai journal of medicine, New York.

[64]  Aldons J. Lusis,et al.  Atherosclerosis : Vascular biology , 2000 .

[65]  R. Garavito,et al.  Cyclooxygenases: structural, cellular, and molecular biology. , 2000, Annual review of biochemistry.

[66]  J. Vane,et al.  Cyclooxygenases 1 and 2. , 1998, Annual review of pharmacology and toxicology.

[67]  T. Wright,et al.  Cytokines in acute and chronic inflammation. , 1997, Frontiers in bioscience : a journal and virtual library.

[68]  C. Franceschi,et al.  The immunology of exceptional individuals: the lesson of centenarians. , 1995, Immunology today.

[69]  R. Nesse,et al.  Evolution and Healing: The New Science of Darwinian Medicine , 1994 .